Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. - Wikidata - thesis-toulmin - TriplyDB

Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States.

Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States.

http://www.wikidata.org/entity/Q36844723

about

Drug-induced liver injury: a clinical update Drug-induced liver injury: present and future Herbal Medicine in Mexico: A Cause of Hepatotoxicity. A Critical Review Hepatotoxicity by Drugs: The Most Common Implicated Agents Drug-Induced Liver Toxicity and Prevention by Herbal Antioxidants: An Overview RUCAM in Drug and Herb Induced Liver Injury: The Update Causes, clinical features and outcomes of drug-induced liver injury in hospitalized patients in a Chinese tertiary care hospital The Need for Biomarkers in Diagnosis and Prognosis of Drug-Induced Liver Disease: Does Metabolomics Have Any Role?Liver Injury from Herbal, Dietary, and Weight Loss Supplements: a Review MicroRNAs in Drug-induced Liver Injury Drug Induced Liver Injury: Review with a Focus on Genetic Factors, Tissue Diagnosis, and Treatment Options Idiosyncratic adverse drug reactions: current concepts Atypical causes of cholestasis N-acetylcysteine for non-paracetamol drug-induced liver injury: a systematic review protocol Recent advances in management of acute liver failure Drug- and Herb-Induced Liver Injury in Clinical and Translational Hepatology: Causality Assessment Methods, Quo Vadis?Pathogenesis of idiosyncratic drug-induced liver injury and clinical perspectives.Tyrosine kinase inhibitors: friends or foe in treatment of hepatic fibrosis?The Importance of Patient-Specific Factors for Hepatic Drug Response and Toxicity A panel of serum microRNAs as specific biomarkers for diagnosis of compound- and herb-induced liver injury in rats HLA alleles influence the clinical signature of amoxicillin-clavulanate hepatotoxicity The impact of duration of treatment on reported time-to-onset in spontaneous reporting systems for pharmacovigilance Profiles of serum cytokines in acute drug-induced liver injury and their prognostic significance Multicenter study of trimethoprim/sulfamethoxazole-related hepatotoxicity: incidence and associated factors among HIV-infected patients treated for Pneumocystis jirovecii pneumonia High Dose Atorvastatin Associated with Increased Risk of Significant Hepatotoxicity in Comparison to Simvastatin in UK GPRD Cohort Research Advances on Hepatotoxicity of Herbal Medicines in China Hepatotoxicity of targeted therapy for cancer.Chronic Cholestatic Liver Injury Attributable to Vedolizumab.Autoimmune-like drug-induced liver injury: a review and update for the clinician.Chronic liver injury induced by drugs: a systematic review.Clinical and histological features of idiosyncratic acute liver injury caused by temozolomide.Characterizing phenotypes and outcomes of drug-associated liver injury using electronic medical record data.An automated causality assessment algorithm to detect drug-induced liver injury in electronic medical record data.Prevalence of antibiotic use: a comparison across various European health care data sources.The incidence, presentation, outcomes, risk of mortality and economic data of drug-induced liver injury from a national database in Thailand: a population-base study.The characteristics and clinical outcome of drug-induced liver injury in a Chinese hospital: A retrospective cohort study.Penicillinase-resistant antibiotics induce non-immune-mediated cholestasis through HSP27 activation associated with PKC/P38 and PI3K/AKT signaling pathways Relationship between characteristics of medications and drug-induced liver disease phenotype and outcome.Azathioprine and 6-Mercaptopurine-induced Liver Injury: Clinical Features and Outcomes Use of transcriptomics in understanding mechanisms of drug-induced toxicity

P2860

Q24617074-1E1C3B0F-4891-4E0D-B6EE-96CC5CEA3483 Q24630227-D66234F4-C776-4181-8A25-E3E98D14EA0D Q26764922-139546C1-DBCF-4D3A-BCCD-5A2168A0B71C Q26767251-CA2FD3F6-F1E0-44C1-8215-5EC154DAADB1 Q26767516-2FB2B0FD-BE80-45DE-9E27-0673B3171BF3 Q26771817-F7537E3F-A238-4DA9-BC4A-53884D9BD5A6 Q26772063-C0B49B52-D121-468F-85CD-F299B6C8815D Q26772999-35FA550C-02AE-41F0-85EE-F02E27D73E81 Q26781749-DACE646D-41A1-443B-AC03-ABA623443998 Q26781801-F8479CEA-C6C2-4387-BF58-FE76D99193F5 Q26781892-A78ECD73-92BB-42EB-874C-7B9A5EAA2671 Q26824391-4041563D-8A0B-443B-859F-51DDB26BDF5E Q27013650-F5DB1314-CB63-418F-A1F3-5E34EA577B94 Q27014948-1306EFAD-7ADD-4B5D-AAF6-0E8C887B17C7 Q27028034-391656DE-3591-4DD0-AF48-4ABFCEA545FD Q27030822-9BA887C9-883E-4405-AB08-FCCF550C921F Q27690772-964A2A72-ED86-491A-97DC-26716DD7C55C Q28068710-E9C3C0BD-335C-470C-B070-E3B73E83CB49 Q28080256-EC625AE3-53F1-44F8-8C37-B32A900F4423 Q28483810-2D81D5DD-3D62-4E1D-826E-2A2DD483FF87 Q28534593-1BEFEDB0-F255-4479-8A74-2748DCB82258 Q28534667-C395FB12-01EF-4220-A43B-DC27CDFDE04F Q28538041-5C647E2E-90CC-4E75-90A9-2673A145A560 Q28542714-49C468A1-8D9A-45D8-B8E4-03B8A89471BF Q28550768-2C25F923-9A56-4987-AAAF-20161AC012AA Q30239062-366EAFB3-E160-48F2-B9D5-02D93E2E526D Q30250288-34A2C59A-EFE6-4E60-9F07-75C95F8866C3 Q30275619-2ED712A5-4E02-4D01-AEF4-C08AA96B7837 Q30276377-CA4F9E4F-0172-4688-BBDF-B4DBC06BEE6D Q30278737-A8B6DD9B-CCDF-47F5-98C7-A81B0AD5AE19 Q30447260-D56C887C-EA72-42A9-AADB-252656B961A4 Q30582650-F80E97B4-A0AE-47E0-8754-BBF4F0D69297 Q30830530-CBE6A351-6912-4B01-9247-7FAA1BD881D6 Q30979118-3E55D764-FCFB-4347-B76C-A5826688FBB7 Q31139774-7762997F-3C42-40C4-8059-6DBF5743DE2E Q33590645-9B428CF8-2518-465C-B24E-DB525E46F564 Q33687525-8FDC3FA1-C861-4F72-9FA1-9A34F0000E38 Q33784830-B42E74C9-FB04-4A3D-871D-ABB33E92AD23 Q33894632-DE60F7E5-DD95-4CF3-863C-17E8B198EBDF Q33909001-AA6809D3-D3BD-4018-894E-A75ED2DA45B2

P2860

Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States.

http://www.wikidata.org/entity/Q36844723

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Causes, clinical features, and ...... r injury in the United States.

@en

type

label

Causes, clinical features, and ...... r injury in the United States.

@en

prefLabel

Causes, clinical features, and ...... r injury in the United States.

@en

P1433

Q36844723-4BA14A0B-9FA2-41E4-BA1E-CE7AF7E9981A

P1476

Q36844723-7BF56C2C-2E17-4049-BE7D-D53AA63276DD

P2093

Q36844723-0ACE05FA-E50A-488F-B21C-FC078E3165D8

Q36844723-108BD8ED-445E-4CF4-B43D-69AD70582FDF

Q36844723-55E600F4-6454-4479-82F4-177257DE3545

Q36844723-570DC800-08AA-488F-AB5C-18C7BB5B9AFE

Q36844723-57E6DCA2-1283-4156-9485-FEA2B80707EA

Q36844723-5A6C8165-E679-43A3-94B3-02274CBE60F0

Q36844723-98A1A1C5-8DCF-46A9-9DBC-4C9E15AD9734

Q36844723-B36B17CA-1F8D-4141-A289-59FD4FACBA4E

Q36844723-EA2D86EA-B812-4BA2-B13D-82B7B4CE03E3

P2860

Q36844723-08BB7833-722E-45C8-8B78-C2C8B996BABB

Q36844723-148FF5D2-55C9-4606-9360-E84DB3148462

Q36844723-191F42AE-D1AF-4D56-ABA0-37BFEF31D84B

Q36844723-1964EAA8-DB95-4B0A-AB49-BB6435EB8750

Q36844723-2A99AA83-5D34-4CD1-91FD-C335120D45A8

Q36844723-2C359FA2-D780-4CB6-9897-15CE8A24B8F3

Q36844723-2CB80303-54C3-4590-A43B-BF471551DB5B

Q36844723-3FDFAAB5-D2A7-4301-86B7-549B2C8664E6

Q36844723-45872C3D-1942-4650-B0BF-7AD6E182B498

Q36844723-4C578CEA-C7FE-4BD3-AA9C-191BD13C1666

P304

Q36844723-6444D2EE-7F2C-4DDB-A0FC-8EF6FEDCD144

P31

Q36844723-A06D9F19-FFDF-43FA-A7D8-506499399C70

P356

Q36844723-E716D597-95F3-405B-B4EF-4A0864572304

P407

Q36844723-8695E7AD-DCEF-45C9-A24B-088976620C65

P433

Q36844723-A28F293D-5D2A-4DDB-8008-5C678032828C

P478

Q36844723-6365E3BE-2ACF-4974-864F-F68488A6AF91

P577

Q36844723-31054023-826F-49BB-A55A-ABBBB39C0788

P5875

Q36844723-11D8903D-BC29-4483-B8B1-F576B2A43CC3

P698

Q36844723-BFD0C346-D8F0-48E7-B877-0ED7FA8797FD

P932

Q36844723-67D10A95-4959-47E8-AEC6-6A3889A5E112

P356

J.GASTRO.2008.09.011

P1433

Gastroenterology

P1476

Causes, clinical features, and ...... r injury in the United States.

@en

P2093

Drug Induced Liver Injury Network (DILIN)

http://www.w3.org/2001/XMLSchema#string

Herbert L Bonkovsky

http://www.w3.org/2001/XMLSchema#string

Hongqiu Yang

http://www.w3.org/2001/XMLSchema#string

James Rochon

http://www.w3.org/2001/XMLSchema#string

Jose Serrano

http://www.w3.org/2001/XMLSchema#string

Naga Chalasani

http://www.w3.org/2001/XMLSchema#string

Paul B Watkins

http://www.w3.org/2001/XMLSchema#string

Robert J Fontana

http://www.w3.org/2001/XMLSchema#string

Timothy Davern

http://www.w3.org/2001/XMLSchema#string

P2860

Idiosyncratic drug reactions: past, present, and future

Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States.

Criteria of drug-induced liver disorders. Report of an international consensus meeting.

Outcome and prognostic markers in severe drug-induced liver disease.

Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period.

Drug-related hepatotoxicity.

Association between consumption of Herbalife nutritional supplements and acute hepatotoxicity.

Herbal does not mean innocuous: ten cases of severe hepatotoxicity associated with dietary supplements from Herbalife products.

Adverse hepatic drug reactions: inflammatory episodes as consequence and contributor.

Pharmacogenomics and individualized drug therapy.

P304

1924-34, 1934.e1-4

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/J.GASTRO.2008.09.011

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

135

http://www.w3.org/2001/XMLSchema#string

P577

2008-09-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23422836

http://www.w3.org/2001/XMLSchema#string

P698

18955056

http://www.w3.org/2001/XMLSchema#string

P932

3654244

http://www.w3.org/2001/XMLSchema#string